Suraksha
Live Price
Recent news and updates for SURAKSHA will appear here soon.
"Caution advised for SURAKSHA investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.
As of the latest market session, Suraksha (SURAKSHA) is trading at ₹271.55, representing a move of 1.23% from the previous close.
Suraksha is listed and traded under the ticker symbol SURAKSHA on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Suraksha's stock price moved by 1.23%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 18% bullish probability for SURAKSHA stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Suraksha shares reached a high of ₹352.5 and hit a low of ₹224.1.
SURAKSHA exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 44,100 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Suraksha has a market capitalization of ₹1414.25 Cr, designating its size class inside the Healthcare sector.
Suraksha has a current dividend yield of 19.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Suraksha's trailing Price-to-Earnings (P/E) ratio is 44.01. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Suraksha (SURAKSHA) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Suraksha's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore SURAKSHA's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for SURAKSHA are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Suraksha operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.